Search - tctmd.com

Displaying 621 - 640 of 731

Sort: Relevancy | Date

News Daily News

DAPT Interruption At Least 1 Month After ZES Implantation Appears Safe

Yael L. Maxwell

February 17, 2014

News Daily News

DUTCH PEERS Publicado: Los Stents liberadores de Zotarolimus y Everolimus de 3ª Generación son Equivalentes

February 12, 2014

News Daily News

Comparados con los SMD, los SLE Reducen la Revascularización con Independencia de la Severidad de la Enfermedad Renal

January 09, 2014

News Daily News

Un Análisis Revela que, comparados con los SMD, los SLF Reducen la RVD pero No la Mortalidad en Pacientes Muy Ancianos

December 30, 2013

News Conference News TCT 2013

LEVANT 2, RIBS Show Promise for Paclitaxel-Coated Balloons in PAD and CAD

October 30, 2013

Presentation TCT 2013

Evolution of the AUC Terminology, and Current Recommendations in Stable CAD

Presenter: Manesh Patel

October 28, 2013

Presentation TCT 2013

Late Loss in Japanese and US CAD Patients: A Collaborative Advance in Understanding Transpacific Poolability

Presenter: Fumiaki Ikeno

October 27, 2013

News Daily News

Los Stents-Injertos Innovadores son Seguros y Viables en Aneurismas Aórticos Complejos de Alto Riesgo

Yael L. Maxwell

October 25, 2013

News Daily News

Longer DAPT Duration Reduces Adverse Events After PCI for In-Stent Restenosis

Caitlin E. Cox

October 23, 2013

News Daily News

EXECUTIVE: Xience Performs Well in Patients with Less Complex Multivessel Disease

October 15, 2013

News Daily News

La Estrategia Balón liberador de Paclitaxel + SMD es Pobre comparada con los SLE en el Tratamiento de la Estenosis De Novo

October 15, 2013

News Daily News

无并发症DES患者长期使用阿司匹林与双联疗法效果相同

Jason Kahn

October 11, 2013

News Daily News

Long-term Aspirin as Effective as Dual Therapy in Uncomplicated DES Patients

Jason Kahn

October 11, 2013

News Daily News

La Aspirina a Largo Plazo es tan Eficaz como la Terapia Doble en Pacientes SLF Sin Complicaciones

Jason Kahn

October 11, 2013

Presentation

Optimal Duration Of Dual Antiplatelet Therapy After DES Implantation

Presenter: C.W. Lee

October 10, 2013

Presentation

A Clinical and Angiographic Study of the Xience V EES in the Treatment of Multivessel CAD

Presenter: Flavio Ribichini

September 23, 2013

News Daily News

DESSOLVE I: Bioabsorbable Polymer SES Shows Promise in De Novo Lesions

Yael L. Maxwell

September 20, 2013

News Daily News

DESSOLVE I: SLS de Polímero Bioabsorbible, Prometedor en Lesiones De Novo

Yael L. Maxwell

September 20, 2013

Presentation

HOST-ASSURE: Adjunctive Cilostazol vs. Double-Dose Clopidogrel After DES Implantation

Presenter: K. W. Park

September 17, 2013

Presentation

Meta-analysis of Everolimus-Eluting vs. Paclitaxel-Eluting Stents in CAD

Presenter: George D. Dangas

September 16, 2013

Advertisement

DAPT Interruption At Least 1 Month After ZES Implantation Appears Safe

DUTCH PEERS Publicado: Los Stents liberadores de Zotarolimus y Everolimus de 3ª Generación son Equivalentes

Comparados con los SMD, los SLE Reducen la Revascularización con Independencia de la Severidad de la Enfermedad Renal

Un Análisis Revela que, comparados con los SMD, los SLF Reducen la RVD pero No la Mortalidad en Pacientes Muy Ancianos

LEVANT 2, RIBS Show Promise for Paclitaxel-Coated Balloons in PAD and CAD

Evolution of the AUC Terminology, and Current Recommendations in Stable CAD

Late Loss in Japanese and US CAD Patients: A Collaborative Advance in Understanding Transpacific Poolability

Los Stents-Injertos Innovadores son Seguros y Viables en Aneurismas Aórticos Complejos de Alto Riesgo

Longer DAPT Duration Reduces Adverse Events After PCI for In-Stent Restenosis

EXECUTIVE: Xience Performs Well in Patients with Less Complex Multivessel Disease

La Estrategia Balón liberador de Paclitaxel + SMD es Pobre comparada con los SLE en el Tratamiento de la Estenosis De Novo

无并发症DES患者长期使用阿司匹林与双联疗法效果相同

Long-term Aspirin as Effective as Dual Therapy in Uncomplicated DES Patients

La Aspirina a Largo Plazo es tan Eficaz como la Terapia Doble en Pacientes SLF Sin Complicaciones

Optimal Duration Of Dual Antiplatelet Therapy After DES Implantation

A Clinical and Angiographic Study of the Xience V EES in the Treatment of Multivessel CAD

DESSOLVE I: Bioabsorbable Polymer SES Shows Promise in De Novo Lesions

DESSOLVE I: SLS de Polímero Bioabsorbible, Prometedor en Lesiones De Novo

HOST-ASSURE: Adjunctive Cilostazol vs. Double-Dose Clopidogrel After DES Implantation

Meta-analysis of Everolimus-Eluting vs. Paclitaxel-Eluting Stents in CAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content